ANTHONY C. KEECH
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Surgery top 0.05%
- Lipoproteins and Cardiovascular Health
Papers in
- Surgery 88
- Lipoproteins and Cardiovascular Health 75
-
- Acute Myocardial Infarction Research 8
- Co-authors
- Marc Steven Sabatine (45 shared papers)Robert Patrick Giugliano (43 shared papers)Terje Rolf Pedersen (26 shared papers)Peter Sever (17 shared papers)Sabina A. Murphy (23 shared papers)Scott M. Wasserman (11 shared papers)Narimon Honarpour (14 shared papers)Julia Kuder (9 shared papers)
- Journals
- The Medical Journal of Australia (28 papers)Circulation (20 papers)Journal of the American College of Cardiology (13 papers)Atherosclerosis (11 papers)Diabetologia (10 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
ANTHONY C. KEECH
284 papers receiving 19.8k citations
ANTHONY C. KEECH's Hit Papers
Peers
Comparison fields: 5 of 173
- Endocrinology, Diabetes and Metabolism 4.2k
- Surgery 9.5k
- Cardiology and Cardiovascular Medicine 3.8k
- Ophthalmology 927
- Cancer Research 1.4k
Countries citing papers authored by ANTHONY C. KEECH
This map shows the geographic impact of ANTHONY C. KEECH's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ANTHONY C. KEECH with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ANTHONY C. KEECH more than expected).
Fields of papers citing papers by ANTHONY C. KEECH
This network shows the impact of papers produced by ANTHONY C. KEECH. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ANTHONY C. KEECH. The network helps show where ANTHONY C. KEECH may publish in the future.
Co-authors
The 25 scholars most cited alongside ANTHONY C. KEECH, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 295 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease Hit paper breakdown → | 2017 | 4292 |
| 2 | Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial Hit paper breakdown → | 2007 | 862 |
| 3 | Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Hit paper breakdown → | 2019 | 682 |
| 4 | Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease Hit paper breakdown → | 2017 | 558 |
| 5 | Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial Hit paper breakdown → | 2017 | 512 |
| 6 | Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial Hit paper breakdown → | 2017 | 451 |
| 7 | 2008 | 431 | |
| 8 | 2003 | 388 | |
| 9 | 1996 | 368 | |
| 10 | 1995 | 359 | |
| 11 | Cognitive Function in a Randomized Trial of Evolocumab Hit paper breakdown → | 2017 | 359 |
| 12 | 2000 | 307 | |
| 13 | 2010 | 284 | |
| 14 | Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease Hit paper breakdown → | 2022 | 263 |
| 15 | 2006 | 260 | |
| 16 | 2003 | 260 | |
| 17 | 2009 | 252 | |
| 18 | Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial Hit paper breakdown → | 2020 | 244 |
| 19 | 2015 | 240 | |
| 20 | Inflammatory and Cholesterol Risk in the FOURIER Trial Hit paper breakdown → | 2018 | 216 |
About ANTHONY C. KEECH
ANTHONY C. KEECH is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Statistics, Probability and Uncertainty and Ophthalmology, having authored 295 papers that have together received 20.7k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (75 papers), Health Systems, Economic Evaluations, Quality of Life (32 papers), Meta-analysis and systematic reviews (19 papers), Retinal Diseases and Treatments (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers), Statistical Methods in Clinical Trials (10 papers), Acute Myocardial Infarction Research (8 papers) and Diabetes Treatment and Management (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.2k citations), Surgery (9.5k citations), Cardiology and Cardiovascular Medicine (3.8k citations), Ophthalmology (927 citations) and Cancer Research (1.4k citations). ANTHONY C. KEECH has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Marc Steven Sabatine, Robert Patrick Giugliano, Terje Rolf Pedersen, Peter Sever, Sabina A. Murphy, Scott M. Wasserman, Narimon Honarpour, Julia Kuder, Huei Wang and Stephen D. Wiviott. Their work appears in journals such as The Medical Journal of Australia, Circulation, Journal of the American College of Cardiology, Atherosclerosis and Diabetologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.